Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Yanaba

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of the Rheumatic Diseases|April 15, 2004
Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosisK Yanaba, K Takehara, S Sato
The British Journal of Dermatology|January 17, 2007
Taxane-induced sclerodermaM Itoh, K Yanaba, T Kobayashi, et al.
The British Journal of Dermatology|October 19, 2007
Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombinationK Yanaba, H Nakagawa, Y Takeda, et al.
Clinical and Experimental Rheumatology|August 29, 2003
Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosisK Yanaba, M Hasegawa, Y Hamaguchi, et al.
Annals of the Rheumatic Diseases|October 14, 2004
Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosisM Hasegawa, S Sato, K Yanaba, et al.
Clinical and Experimental Dermatology|March 4, 2008
Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibodyK Komura, K Yanaba, F Ogawa, et al.
Annals of the Rheumatic Diseases|December 14, 2005
Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosisK Yanaba, K Komura, M Kodera, et al.
Rheumatology (Oxford, England)|March 31, 2005
Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosisI Hayakawa, M Hasegawa, T Matsushita, et al.
Rheumatology (Oxford, England)|July 22, 2004
Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosisS Sato, M Fujimoto, M Hasegawa, et al.
Dermatology (Basel, Switzerland)|August 12, 2006
A clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the diseaseM Fujimoto, M Hasegawa, Y Hamaguchi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of the Rheumatic Diseases|April 15, 2004
Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosisK Yanaba, K Takehara, S Sato
The British Journal of Dermatology|January 17, 2007
Taxane-induced sclerodermaM Itoh, K Yanaba, T Kobayashi, et al.
The British Journal of Dermatology|October 19, 2007
Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombinationK Yanaba, H Nakagawa, Y Takeda, et al.
Clinical and Experimental Rheumatology|August 29, 2003
Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosisK Yanaba, M Hasegawa, Y Hamaguchi, et al.
Annals of the Rheumatic Diseases|October 14, 2004
Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosisM Hasegawa, S Sato, K Yanaba, et al.
Clinical and Experimental Dermatology|March 4, 2008
Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibodyK Komura, K Yanaba, F Ogawa, et al.
Annals of the Rheumatic Diseases|December 14, 2005
Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosisK Yanaba, K Komura, M Kodera, et al.
Rheumatology (Oxford, England)|March 31, 2005
Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosisI Hayakawa, M Hasegawa, T Matsushita, et al.
Rheumatology (Oxford, England)|July 22, 2004
Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosisS Sato, M Fujimoto, M Hasegawa, et al.
Dermatology (Basel, Switzerland)|August 12, 2006
A clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the diseaseM Fujimoto, M Hasegawa, Y Hamaguchi, et al.
Pageof 2